Viatris Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report4 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Viatris Inc
19.09
−7.71%
vs ±7.5% implied · ×1.03
shaded = implied · ▲▼ = realized
Largest filed tie
11.00%
of VTRS revenue · Cencora, Inc. (formerly AmerisourceBergen Corporation)
Viatris has 5 disclosed suppliers and 5 disclosed customers in SEC filings.
Note…less than 10% of consolidated net sales during the period
| Percentage of Consolidated Net Sales | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cencora, Inc. | 11% | 12% | 10% |
basisVTRS FY2025 revenue $14.3B
SentenceViatris Pty Ltd., a subsidiary of Viatris Inc., for the commercialization of Twyneo and Epsolay in Australia and New Zealand.
VTRS 10-Kaccession 0001792044-26-000013
SentenceUnder the terms of the original agreements, the development programs and certain personnel for selatogrel and cenerimod were transferred to Viatris from Idorsia in exchange for an upfront payment to Idorsia of $350 million, potential contingent milestone payments (including $300 million payable upon the achievement of certain development and regulatory milestones, and $2.1 billion payable upon the achievement of certain tiered sales milestones), as well as potential contingent tiered sales royalties.
VTRS 10-Kaccession 0001792044-25-000008
SentenceThe decrease was primarily due to upfront licensing payments to Mapi of $75.0 million related to additional products under development recorded during the prior year.
VTRS 10-Kaccession 0001792044-25-000008
Expected move
Inputs8Q avg ±8.7%·×0.72·cheap
straddle ±7.4%
spot 19.04exp Nov 20ATM strike 19ATM straddle 1.65IV 45%